Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 7Unknown 5Not yet recruiting 3Terminated 1Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 70Prostatic Neoplasms 5Ovarian Neoplasms 5Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Stomach Neoplasms 4Lymphedema 4Triple Negative Breast Neoplasms 3Lung Neoplasms 3Colorectal Neoplasms 3Anxiety Disorders 3Uterine Cervical Neoplasms 2Melanoma 2Fatigue 2Depression 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Breast Cancer Metastatic 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Tinnitus 1Thyroid Neoplasms 1Tension-Type Headache 1TNBC 1Stroke 1Stress Disorders, Post-Traumatic 1Squamous Cell Carcinoma of Head and Neck 1Spinal Stenosis 1Spinal Cord Injuries 1Small Cell Lung Carcinoma 1

Interventions

Vitamin D 1Synbiotics 1Prebiotics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Chemotherapy-Related Cognitive Impairment × Breast × Clear all
NCT07465497 2026-03-12

Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer

Instituto Jalisciense de Cancerologia

Phase NA Enrolling by invitation
80 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡